Wordt geladen...
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
BACKGROUND: Several studies have identified the decreased expression of the tumor suppressor miR-101 in various cancers. In this study, we tested miR-101 as a potential therapeutic target and novel plasma biomarker for gastric cancer (GC). RESULTS: The miR-101 expression level was significantly lowe...
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739754/ https://ncbi.nlm.nih.gov/pubmed/29290969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20860 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|